Literature DB >> 26555674

Compliance of psychotropic drug prescription with clinical practice guidelines in older inpatients.

Fanny Etchepare1,2, Elodie Pambrun1, Bernard Bégaud1,2,3, Hélène Verdoux1,2,4, Marie Tournier1,2,4.   

Abstract

Several practice guidelines were published by French regulatory agencies between 2006 and 2009 to improve psychotropic drug use in older patients. The objectives of the study were to assess compliance with these guidelines in older patients hospitalized in psychiatric units and to identify characteristics associated with compliance. A cross-sectional study was conducted in 117 patients aged 65 years and older hospitalized in two psychiatric departments of a public hospital, at three dates randomly chosen between January and May 2014. Medical and sociodemographic characteristics were collected from electronic medical records. In all, 8% of psychotropic prescriptions were compliant with guidelines. A total of 98% of antidepressant prescriptions complied with guidelines for product selection (no tricyclics) and 72% for initial dosage (half of that recommended for younger adults). Regarding benzodiazepines, short half-life drugs were chosen in 73% of treatments, low maintenance dosage was found in 64% of treatments, and a discontinuous administration rhythm was noted in 33% of treatments. Regarding antipsychotics, initial dosage was a quarter of the allowed initial dosage for younger adults in 39% of prescriptions and metabolic blood testing was performed in 17% of prescriptions. Neurological and cognitive tolerance was monitored in 41% and 61% of prescriptions, respectively. Few clinical factors were found to be associated with compliance or noncompliance with guidelines in older psychiatric inpatients. Practice guidelines on psychotropic drug prescription were partially respected in older inpatients. Practitioners should take into account the risks associated with non-recommended patterns of psychotropic drug use in this vulnerable population.
© 2015 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Keywords:  antidepressant; antipsychotic; benzodiazepine; older people; practice guidelines; psychotropic drugs

Mesh:

Substances:

Year:  2015        PMID: 26555674     DOI: 10.1111/fcp.12167

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  3 in total

1.  Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice.

Authors:  Janitza L Montalvo-Ortiz; Daniel W Fisher; Guadalupe Rodríguez; Deyu Fang; John G Csernansky; Hongxin Dong
Journal:  Psychopharmacology (Berl)       Date:  2017-04-18       Impact factor: 4.530

2.  Misuse of benzodiazepines: Prevalence and impact in an inpatient population with psychiatric disorders.

Authors:  Arnaud Panes; Hélène Verdoux; Annie Fourrier-Réglat; Driss Berdaï; Antoine Pariente; Marie Tournier
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

Review 3.  Benzodiazepine high-doses: The need for an accurate definition.

Authors:  Jean-Marc Cloos; Christopher Y S Lim Cow; Valéry Bocquet
Journal:  Int J Methods Psychiatr Res       Date:  2021-07-31       Impact factor: 4.035

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.